The Centers for Disease Control and Prevention debuted a new public health awareness campaign this week focused on educating ...

US Health Secretary Robert F. Kennedy Jr. has slashed government spending on mRNA vaccine research. Experts warn it will boost global vulnerability to future pandemics.

Cancer research is an ever-evolving field, driven by the pressing need to understand and combat a disease that remains a leading cause of morbidity and ...

The U.S. Food and Drug Administration said on Friday it has approved Boehringer Ingelheim's drug for patients with a type of ...

With the FDA approval of its zongertinib in certain non-small cell lung cancer (NSCLC) patients, 175-year-old Boehringer ...

The FDA approved Hernexeos (zongertinib tablets, Boehringer Engelheim) for the treatment of adults with unresectable or metastatic NSCLC, Boehringer Ingelheim announced in a press release. It is the ...

The FDA approved multiple groundbreaking treatments in July, enhancing options across patient populations. The FDA maintained its momentum in July, issuing a wave of drug approvals across diverse ...